Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Tenecteplase na 4,5 uur: geen klinisch voordeel bij ischemische beroerte
jul 2024 | Neuro-vasculair